BRKRP
Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A
NASDAQ · Healthcare · Medical - Devices · US
$439.45
+0.33%Aug 15, 2026, 07:21 UTC
Bank of America Corp DE reduced its stake in Bruker Corporation by 3.2% during the quarter, selling 30,371 shares, according to a Form 13F filing.
Source:Aug 4, 2026, 00:00 UTC
Bruker Corp reported Q2 2026 total revenue of $838.5 million, a 5.2% increase year-over-year, with a GAAP diluted loss per share of $0.41 and non-GAAP diluted EPS of $0.49, and provided FY2026 guidance for organic revenue growth of 1-2% and non-GAAP EPS of $2.10-$2.15.
Jul 15, 2026, 11:00 UTC
Bruker Corporation acquired the DISQVER clinical metagenomics platform from Noscendo GmbH to expand its infection detection portfolio.
Source:Jun 9, 2026, 00:00 UTC
Quanterix Corp appointed Jason Faessler as Chief Financial Officer and Treasurer, effective June 22, 2026.
Source:Jun 2, 2026, 15:24 UTC
Bruker Corporation launched the new timsMRMS mass spectrometry platform for ultra-complex mixture applications in the energy industry.
Source: